Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review.

Meifang Zhao, Jingnan Sun, Shanshan Liu, Hongqiong Fan, Yu Fu, Yehui Tan, Sujun Gao

Abstract readCase ReportsReview

In one paragraph

Review in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meifang ZhaoThe First Hospital of Jilin University, Changchun, China.ORCID https://orcid.org/0000-0002-0077-3893

Jingnan SunThe First Hospital of Jilin University, Changchun, China.

Shanshan LiuThe First Hospital of Jilin University, Changchun, China.

Hongqiong FanThe First Hospital of Jilin University, Changchun, China.

Yu FuThe First Hospital of Jilin University, Changchun, China.

Yehui TanThe First Hospital of Jilin University, Changchun, China.

Sujun GaoThe First Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) are a heterogeneous group of hematologic malignancies characterized by dysplastic and myeloproliferative overlapping features in the bone marrow and blood. The occurrence of the disease is related to age, prior history of MPN or MDS, and recent cytotoxic or growth factor therapy, but it rarely develops after acute myeloid leukemia (AML). We report a rare case of a patient diagnosed with AML with t(8; 21)(q22; q22) who received systematic chemotherapy. After 4 years of follow-up, MDS/MPN-unclassifiable occurred without signs of primary AML recurrence.

Indexed as

Hematologic NeoplasmsLeukemia, Myeloid, AcuteMyelodysplastic-Myeloproliferative DiseasesMyelodysplastic SyndromesBone MarrowHumansacute myeloid leukemiaBCR/ABL1 negativecase reportMyelodysplastic/myeloproliferative neoplasm-unclassifiablemyeloid malignancyRunt-related transcription factor 1/RUNX1 partner transcriptional co-repressor 1 mutation

Identifiers

PMID34057843

DOI10.1177/03000605211018426

PMCPMC8753788

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.